ArticleJournal of veterinary internal medicine2026
Clinical features, diagnostic findings, and outcomes of emphysematous cholecystitis in 35 dogs: a retrospective case series.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmphysematous cholecystitis (EC) is a rare and severe variant of acute cholecystitis in dogs. Published data regarding EC are limited. HYPOTHESIS/
objectivesTo retrospectively describe the clinical presentation, relevant laboratory values, ultrasonographic findings, bile cytology, bacterial culture and susceptibility results, gallbladder histopathology, treatment, and outcomes in a group of dogs diagnosed with EC. ANIMALS: Thirty-five client-owned dogs diagnosed with EC.
methodsA retrospective review of medical records from 4 referral veterinary teaching hospitals between January 2000 and December 2024 was conducted to describe dogs diagnosed with EC via ultrasonography or computed tomography.
resultsCommon clinical signs reported included vomiting (23/35, 66%), lethargy (23/35, 66%), or inappetence (15/35, 43%) in dogs. Common clinicopathologic abnormalities were an inflammatory leukogram (21/31, 68%) and elevated serum liver enzyme activity with or without hyperbilirubinemia (28/33, 85%). The most frequent bacteria isolated were Escherichia coli (13/36 isolates) and Clostridium spp. (12/36 isolates). Postoperative death among dogs that underwent cholecystectomy was 29% (4/14). Eleven of 35 (31%) dogs were treated medically and survived to discharge and 5 of 6 dogs with long-term follow-up survived > 6 months. CONCLUSIONS AND CLINICAL IMPORTANCE: Dogs with EC often present as clinically ill with an inflammatory leukogram, elevated serum liver enzyme activity, and mild hyperbilirubinemia. Cholecystectomy permits source control and collection of gallbladder culture to guide antimicrobial therapy, but empirical medical management can be successful.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.